# Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)

> **NCT04345861** · PHASE2,PHASE3 · TERMINATED · sponsor: **University Hospital, Montpellier** · enrollment: 7 (actual)

## Conditions studied

- Coronavirus Infection
- Pneumonia, Viral

## Interventions

- **DRUG:** Hydroxychloroquine + placebo
- **DRUG:** hydroxychloroquine + azithromycin

## Key facts

- **NCT ID:** NCT04345861
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-11
- **Primary completion:** 2021-02-09
- **Final completion:** 2021-04-09
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** halted prematurely.
- **Last updated:** 2021-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04345861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04345861, "Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04345861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*